Depresión y cáncer: una revisión orientada a la práctica clínica

Hernández M, Cruzado JA, Prado C, Rodríguez E, Hernández C, González MA, et al. Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 2012;9(2-3):233-57.

https://doi.org/10.5209/rev_PSIC.2013.v9.n2-3.40895

Hernádez M, Cruzado JA, Arana Z. Problemas psicológicos en pacientes con cáncer: dificultades de detección y derivación al psicooncólogo. Psicooncología. 2007;4:179-91.

United States Center for Disease Control and Prevention. Cancer Incidence and Mortality Data Disponible en: http://apps.nccd.cdc.gov/uscs/

Gil Moncayo FL, Costa Requena G, Javier Pérez F, Salamero M, Sánchez N, Sirgo A. Adaptación psicológica y prevalencia de trastornos mentales en pacientes con cáncer. Medicina clínica. 2008;130(3):90-2.

https://doi.org/10.1157/13115354

Kadan-Lottick NS, Vanderwerker LC, Block SD, Zhang B, Prigerson HG. Psyquiatric Disorders and mental health service use in patients with advanced cancer- A report from the coping with cancer study. Cancer. 2005;104:2872-81.

https://doi.org/10.1002/cncr.21532

Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER, et al. Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery. 2004;54:358-67.

https://doi.org/10.1227/01.NEU.0000103450.94724.A2

Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol. 2008;10(2):171-81.

https://doi.org/10.1215/15228517-2007-057

Fras I, Litin EM, Pearson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intraabdominal neoplasm. Am J Psychiatry. 1967;123(12):1553-62.

https://doi.org/10.1176/ajp.123.12.1553

Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 2000;18:893-903.

https://doi.org/10.1200/JCO.2000.18.4.893

Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in woman with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004;143:447-51.

Evans DL, McCartney CF, Nemeroff CB, Raft D, Quade D, Golden RN, et al. Depression in woman treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry. 1986;143:447-51.

https://doi.org/10.1176/ajp.143.4.447

Haeffel DJ, Getchell M, Koposov RA, Yrigollen CM, Deyoung CG, Klinteberg BA, et al. Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol Sci. 2008;19:62-9.

https://doi.org/10.1111/j.1467-9280.2008.02047.x

Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160(8):1516-8.

https://doi.org/10.1176/appi.ajp.160.8.1516

Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulated cortex in mood disorders. CNS Spectr. 2008;13(8):663-81.

https://doi.org/10.1017/S1092852900013754

Sen S, Duman R, Sanacora G. Serum BDNF, depression and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64(6):527-32.

https://doi.org/10.1016/j.biopsych.2008.05.005

Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behaviour as a new target for drug development. Trends Pharmacol Sci.1992;13:24-8.

Plotkin SR, Banks WA, Kastin AJ. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroimmunol. 1996;67:41-7.

https://doi.org/10.1111/j.1834-7819.1996.tb05663.x

Rivest S, Lacroix S, Vallieres L, Nadeau S, Zhang J, Laflamme

N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med. 2000;223:22-38.

https://doi.org/10.1046/j.1525-1373.2000.22304.x

Berard RM, Boermeester F, Viljoen G. Depressive disorders in a out-patient oncology setting: prevalence assessment and management. Psychooncology. 1998;7:112-20.

https://doi.org/10.1002/(SICI)1099-1611(199803/04)7:2<112::AID-PON300>3.0.CO;2-W

En: Kissane DW, Maj M, Sartorius N, editors. Depression and cancer, 19. John Wiley & Sons; 2011.

https://doi.org/10.1002/9780470972533

Papanicolaou DA. Euthyroid sick syndrome and the role of cytokines. Rev Endocrinol Metab Dis. 2000;1:43-8.

https://doi.org/10.1023/A:1010060303031

Pelletier G, Verhoef MJ, Khatrei N, Hagan N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41-9.

https://doi.org/10.1023/A:1015728825642

Musselman DL, Lawson DD, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, et al. Paroxetine for the prevention of depres- sion induced by high-dose interferon alpha. N Engl J Med. 2001;344:961-6.

https://doi.org/10.1056/NEJM200103293441303

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med. 2000;160(14):2102-7.

https://doi.org/10.1001/archinte.160.14.2101

Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, et al. Association of depressive syndrome and early deaths among patients after stem-cel transplantation for malignant diseases. J Clin Oncol. 2002;20(8):2118-26.

https://doi.org/10.1200/JCO.2002.08.757

Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R, et al. Cytokines, ''depression due to a general medical condition'', and antidepressant drugs. Adv Exp Med Biol. 1999;461:283-316.

https://doi.org/10.1007/978-0-585-37970-8_16

Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuroon- col. 2002;57(1):41-9.

https://doi.org/10.1023/A:1015728825642

Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression - An independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009;113:127-32.

https://doi.org/10.1016/j.jad.2008.04.002

Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998;(4):1594-600, 16.

https://doi.org/10.1200/JCO.1998.16.4.1594

Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, et al. How successful are oncologists in identifying patient distress, percieved social support, and need for psychosocial counselling? Br J Cancer. 2001;84(2):179-85.

https://doi.org/10.1054/bjoc.2000.1545

Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84(8):1011-5.

https://doi.org/10.1054/bjoc.2001.1724

Weinberger MI, Roth AJ, Nelson CJ. Untangling the complexities of depression diagnosis in older cancer patients. Oncologist. 2009;14(1):60-6.

https://doi.org/10.1634/theoncologist.2008-0147

Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101(21):1464-88.

https://doi.org/10.1093/jnci/djp336

Hernández Blázquez M. Estudio longitudinal del malestar emocional y los trastornos psicopatológicos en pacientes de cáncer que reciben tratamiento de radioterapia. [tesis doctoral]. Madrid: Universidad Complutense de Madrid; 2012.

Miguel C, Albuquerque E. Drug Interaction in psychooncology: antidepressants and antineoplastics. Pharmacology. 2011;88:333-9.

https://doi.org/10.1159/000334738

Stahl B, Goldstein E. Mindfulness para reducir el estrés: una guía práctica. Barcelona: Editorial Kairós; 2011.

Rodríguez Vega B, Bayón Pérez C. Comunicación personal: Integrando mindfulness y psicoterapia. Bilbao: Fundación OMIE y el Servicio de Psiquiatría del Hospital de Basurto; 2013.

Hofmann S, Sawyer A, Witt A, Oh D. The effect of mindfulnessbased therapy on anxiety and depression: A meta-analytic review. J consult clin psychol. 2010;78:169-83.

https://doi.org/10.1037/a0018555

Redondo R. Zen, la experiencia del asombro. Fabrikart: arte, tecnología, industria, sociedad. 2008;8:212-25.

Shennan C, Payne S, Fenlon D. What is the evidence for the use for mindfulness-based interventions in cancer care? Review Psychooncology. 2011;20(7):681-97.

https://doi.org/10.1002/pon.1819

Rodríguez B, Priede A, Maeso A, Arranz H, Palao A. Cambios psicológicos e intervenciones basadas en mindfulness para los supervivientes de un cáncer. Psicooncología. 2011;8: 7-20.

https://doi.org/10.5209/rev_PSIC.2011.v8.n1.1

Watson M, Kissane DW, editores. Handbook of psychotherapy in cancer care. Chichester, West Sussex, UK: Wiley-Blackwell; 2011.

https://doi.org/10.1002/9780470975176

Birnie K, Garland S, Carlson L. Psychological benefits for cancer patients and their partners participating in mindfulness- based stress reduction (MBSR). Psychooncology. 2010;19(9): 1004-9.

https://doi.org/10.1002/pon.1651

Valiente M. El uso de la visualización en el tratamiento psicológico de enfermos de cáncer. Psicooncología. 2006;3(1): 19-34.

Walker LG, Anderson J. Testing complementary and alternative medicine within a research protocol. Eur J Cancer. 1999;35(11):1614-8.

https://doi.org/10.1016/S0959-8049(99)00199-9

Cheung YL, Molasiotiss A, Chang AM. The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psychooncology. 2003;12(3):254-66.

https://doi.org/10.1002/pon.638

Dimeo FC, Thomas F, Rabe-Menssen C, Pröpper F, Mathias M. Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomized controlled trial. Supportive Care Cancer. 2004;12(11):774-9.

https://doi.org/10.1007/s00520-004-0676-4

Baider L, Peretz T, Hadani PE, Koch U. Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 2001;23(5):272-7.

https://doi.org/10.1016/S0163-8343(01)00158-X

Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology. 2001;10(6):490-502.

https://doi.org/10.1002/pon.537

Miller J, Hopkinson C. A retrospective audit exploring the use of relaxation as an intervention in oncology and palliative care. Eur J Cancer Care. 2008;17(5):488-91.

https://doi.org/10.1111/j.1365-2354.2007.00899.x